Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning

Radiotherapy and Oncology

Volumn 95, Issue 2, 2010, Pages 218-224

  Musat, Elena ^a,b   Roelofs, Erik ^b   Bar Deroma, Raquel ^c   Fenton, Paul ^d   Gulyban, Akos ^d   Collette, Laurence ^d   Stupp, Roger ^e   Weber, Damien C ^f   Davis, J Bernard ^g   Aird, Edwin ^h   Baumert, Brigitta G ^b  

^a INSTITUT CURIE   (France)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RAMBAM MEDICAL CENTER   (Israel)

^d EORTC DATA CENTER   (Belgium)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Conformal radiotherapy; Conformity indices; Dummy run; Homogeneity; Low grade gliomas; Quality assurance

Indexed keywords

ANTICONVULSIVE AGENT; ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE; TEMOZOLOMIDE;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; GLIOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTENSITY MODULATED STEREOTACTIC RADIOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; SEIZURE; TREATMENT PLANNING; CANCER STAGING; CENTRAL NERVOUS SYSTEM TUMOR; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; CENTRAL NERVOUS SYSTEM NEOPLASMS; DACARBAZINE; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 77956621835     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.03.005     Document Type: Article

References (25)

1. Bentzen SM. Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother Oncol 1998;46: 5-18. (Pubitemid 28072852)
2. Karim AB, Afra D, Cornu P, et al. Randomised trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: EORTC 22845 with MRC BRO4 study: an interim analysis. Int J Radiat Oncol Biol Phys 2002;52: 316-24.
3. Karim AB, Maat B, Hatlevoll R, et al. A randomised trial on dose-response in radiation therapy of low-grade cerebral glioma: EORTC 22844. Int J Radiat Oncol Biol Phys 1996;36: 549-56.
4. Pace A, Vidiri A, Galie E, et al. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol 2003;14: 1722-6. (Pubitemid 38029042)
5. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomised trial of lowversus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a NCCTG/RTOG/ECOG study. J Clin Oncol 2002;20: 2267-76.
6. Horiot JC, Johansson KA, Gonzalez DG, et al. Quality assurance control in the EORTC cooperative group of radiotherapy. 1. Assessment of radiotherapy staff and equipment. Radiother Oncol 1986;6: 275-84. (Pubitemid 16026733)
7. Bernard Davis J, Reiner B, Dusserre A, et al. Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: the dummy run. Radiother Oncol 2002;64: 65-73. (Pubitemid 35223155)
8. Ataman F, Poortmans P, Stupp R, et al. Quality assurance of the EORTC 26981/ 22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review. Eur J Cancer 2004;40: 1724-30. (Pubitemid 38902908)
9. Matzinger O, Poortmans P, Giraud J-Y, et al. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review. Radiother Oncol 2009;90: 285-90.
10. Budiharto T, Musat E, Poortmans P, et al. Profile of radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century. Radiother Oncol 2008;88: 403-10.
11. Feuvret L, Noel G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys 2006;64: 333-42. (Pubitemid 43083417)
12. Oozeer R, Chauvet B, Garcia R, et al. Dosimetric evaluation of conformal radiotherapy: conformity factor. Cancer Radiother 2000;4: 207-16. (Pubitemid 30415401)
13. van't Riet A, Mak AC, Moerland MA, et al. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys 1997;37: 731-6. (Pubitemid 27175329)
14. Yoon M, Park SY, Shin D, et al. A new homogeneity index based on statistical analysis of the dose-volume histogram. J Appl Clin Med Phys 2007;8: 9-17.
15. De Meerleer GO, Vakaet LA, De Gersem WR, et al. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys 2000;47: 639-48. (Pubitemid 30317481)
16. ICRU Report 50. Prescribing, recording and reporting photon beam radiotherapy. Report 50. Bethesda, MD, USA; 1993.
17. ICRU Report 62. Supplement to ICRU Report 50. Med Phys 1998;25.
18. Knoos T, Kristensen I, Nilsson P. Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index. Int J Radiat Oncol Biol Phys 1998;42: 1169-76. (Pubitemid 29004164)
19. Lomax NJ, Scheib SG. Quantifying the degree of conformity in radiosurgery treatment planning. Int J Radiat Oncol Biol Phys 2003;55: 1409-19. (Pubitemid 36338310)
20. Lefkopoulos D, Schlienger M, Touboul E, et al. Quantitative evaluation of treatment planning for linac multi-isocentric radiosurgery. In: Proceedings of the XIth international conference on ''computers in radiation therapy, " XIth ICCR, Manchester, UK; 1994. p.296-7.
21. Hammer O, Harper DAT, Ryan PD. PAST: statistics software package for education, data analysis. Palaeontol Electron 2001;4: 9.
22. Jiang SB, Sharp GC, Neicu T, et al. On dose distribution comparison. Phys Med Biol 2006;51: 759-76.
23. Wu VW, Kwong DL, Sham JS. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol 2004;71: 201-6. (Pubitemid 38521189)
24. Brahme A. Individualizing cancer treatment: biological optimization models in treatment planning and delivery. Int J Radiat Oncol Biol Phys 2001;49: 327-37. (Pubitemid 32120231)
25. Bentzen SM. Radiation therapy: intensity modulated, image guided, biologically optimized and evidence based. Radiother Oncol 2005;77: 227-30. (Pubitemid 41785329)